CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01015625
NCT01015625N/ACompleted
CompareCT.gov

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer, a Multicenter Prospective Randomized Study to Evaluate the Use of Local Therapy

Austrian Breast & Colorectal Cancer Study Group·interventional·Posted Nov 18, 2009·Updated Aug 19, 2024

In Brief

A clinical study evaluating Surgery and Surgery on Demand for Synchronous Metastasized Breast Cancer and Circulating Tumor Cells. Completed, enrolled 90 participants across 14 sites.

Detailed Summary

Primary Operation in synchronous metastasized invasive breast cancer to evaluate the use of local therapy

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSynchronous Metastasized Breast Cancer, Circulating Tumor Cells
CountriesAustria
CollaboratorsBayer, Amgen, Hoffmann-La Roche, AstraZeneca, Sanofi, Wyeth-Lederle Pharma GmbH, GlaxoSmithKline, Merck Sharp & Dohme LLC, Fond of the Viennese Mayor

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 18, 2009
Enrollment StartNov 24, 2010
Primary CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 11.6 yearsPosted 16.6 years ago

Interventions

Surgeryprocedure

lumpectomy or mastectomy with or without radiotherapy. Sentinel biopsy followed by axillary dissection (level I-II)

Surgery on Demandprocedure

if necessary local therapy on demand